Lung Transplant Recipient with Pulmonary Alveolar Proteinosis.
Sofya TokmanM Frances HahnHesham AbdelrazekTanmay S PanchabhaiVipul J PatelRajat WaliaAshraf OmarPublished in: Case reports in transplantation (2016)
Pulmonary alveolar proteinosis (PAP) is a progressive lung disease characterized by accumulated surfactant-like lipoproteinaceous material in the alveoli and distal bronchioles. This accumulation is the result of impaired clearance by alveolar macrophages. PAP has been described in 11 solid organ transplant recipients, 9 of whom were treated with mammalian target of rapamycin inhibitors. We report a case of a lung transplant recipient treated with prednisone, mycophenolate mofetil (MMF), and tacrolimus who ultimately developed PAP, which worsened when MMF was replaced with everolimus.